Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score.
In a prospective cohort study of 20, 282 gravidas and their offspring, congenital malformation rates were similar in the children of over 1,000 women exposed and those not exposed to two components of Bendectin (doxylamine succinate and dicyclomine hydrochloride) during the first four lunar months of pregnancy. In a cohort reduced to 41,337 mother-child pairs for technical reasons, mean birth weight and perinatal mortality rates were similar according to exposure or nonexposure to either drug, as were intelligence quotient scores measured at four years of age in 28,358 of the children. Control of potential confounding factors with a variety of multivariate techniques did not materially alter these findings.
D000014:Abnormalities, Drug-Induced; D001724:Birth Weight / Q000187:drug effects*; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects*; D004025:Dicyclomine / Q000009:adverse effects*; D004319:Doxylamine / Q000009:adverse effects*; D004781:Environmental Exposure; D005260:Female; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007360:Intelligence / Q000187:drug effects*; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011725:Pyridines / Q000009:adverse effects*; D012189:Retrospective Studies; D014481:United States
D003509:Cyclohexanecarboxylic Acids; D011725:Pyridines; D004025:Dicyclomine; D004319:Doxylamine